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conformality. Dose statistics, estimated delivery time and 
results of dose verification using the Delta(4) (ScandiDos, 
Sweden) were evaluated.  
Results: The treatment plans fulfilled the dose prescription 
except when PTVb was lying adjacent to the spinal cord. In 
these cases, plan quality was strongly influenced by the 
spinal cord constraint. PTVe conformality was found to be 
suboptimal due to the steep 18-8 Gy gradient. The delivery 
time of the plans ranged between 7-9 min. Measured dose 
distributions showed high agreement with calculated ones, 
with more than 99% of the area within the region of interest 




Conclusions: The required plan quality and accuracy in dose 
delivery could be obtained using the differential dosing 
approach for spinal SBRT. 
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Purpose/Objective: Simple low conformity lateral opposing 
radiation beams with limited sparing to proximal organs-at-
risk (OARs) were widely adopted in the past for treating 
palliative whole brain radiation therapy (WBRT). Crucial OARs 
located at skull base used to sacrifice with significant 
radiation dose inevitably. More conformal radiation 
treatments, like helical tomotherapy (HT) and volumetric 
modulated arc therapy (VMAT), are becoming more accepted 
to treat WBRT. These techniques allow not only conformal 
dose to the whole brain but also simultaneous integrated 
boost (SIB) doses to dedicated metastases for superior 
disease control and symptom relief. This study aimed to 
investigate any potential advantages in cochleae and eyes 
sparing between HT and non-coplanar VMAT. 
Materials and Methods: Treatment planning computed 
tomography (CT) scans of 15 brain metastasis patients who 
had received palliative dose WBRTs with SIBs to the 
metastases in the department were recruited. Each patient 
was re-planned with HT and non-coplanar VMAT for 
dosimetric comparison. Departmental routine optimal 
settings with fan beam thickness of 2.5cm and pitch value of 
0.287 were used in all HT plans. One coplanar full arc plus 
two non-coplanar half arcs modulating by Varian Millennium 
120 MLCs were used in all VMAT plans. The two non-coplanar 
half arcs were arranged at 60 degrees offset to each other 
and to the coplanar full arc to cover the cranial hemisphere. 
All target volumes were optimized according to original 
prescriptions. The median whole brain dose was 30Gy (range 
25-40Gy) and the median SIB dose was 35Gy (range 30-45Gy). 
The mean SIB volume was 26.7±30.4cc consisting 1.7±1.8% of 
the whole brain volume 1481.8±161.1cc. Radiation doses to 
cochleae and eyes were studied by comparing their maximum 
doses (Dmax) and mean doses (Dmean). The dose results from 
the two techniques were tested statistically by paired t-test 
considering significant level of p-value <0.05. 
Results: The dose results are listed in Table 1. Non-coplanar 
VMAT significantly achieved lower Dmax and Dmean to both 
cochleae than HT (all p<0.001). Radiation doses to both eyes 
were slightly higher in non-coplanar VMAT than in HT but 
could not be shown statistically significant (all p>0.05). 
However, the Dmax and Dmean to both lens were significantly 
higher in non-coplanar VMAT than in HT (p<0.01 and p<0.001, 
respectively). 
Conclusions: Non-coplanar VMAT is superior to HT in sparing 
cochleae which are relatively small and highly proximal to 
target volumes. There is no significant dose difference in 
eyes sparing for both techniques. Non-coplanar VMAT is 
preferred to treat WBRT with SIB if slight increase in lens 
doses is not a concern. 
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Purpose/Objective: This study investigated the potential 
dosimetric benefit of intensity modulated proton therapy 
(IMPT) over rotational intensity-modulated radiotherapy plans 
for nasopharyngeal carcinoma (NPC) patients. Furthermore, 
their robustness to certain anatomical changes was 
examined. 
Materials and Methods: Ten NPC patients planned using 
VMAT (Monaco), TomoTherapy (TomoHD) and IMPT (XiO). All 
patients were planned to receive 65, 60 and 54 Gy in 30 
fractions to the PTVs of primary, intermediate risk and low 
risk nodal regions, respectively. Plans were compared by 
analysing PTV coverage, mean and maximum doses to normal 
structures. Significance testing between techniques was 
performed using the Wilcoxon signed-rank test. 
For robustness comparison between IMPT and VMAT plans, 
each planning CT was artificially modified to simulate (i) 
partial nasal cavity filling and (ii) weight loss (using a 
commercial simulation software, ImSimQA). Dose 
distributions were re-calculated on each artificial CT as 
quality assurance procedure to retaining exactly the same 
parameters and compared against the original dose 
distributions to reveal the dosimetric consequences of each 
anatomical change for the two treatment options. 
Results: All modalities were able to produce plans that would 
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be clinically acceptable for treatment while achieving critical 
serial organ dose constraints, with representative results 
shown in Figure 1. IMPT revealed significantly better PTV 
conformity (p=0.008) and significant reductions in mean dose 
to several distant structures including larynx (p=0.002) and 
brain (p=0.006) against both VMAT and TomoHD plans. 
 
IMPT plans were more susceptible to anatomical changes 
compared to VMAT in nasal cavity filling simulation (e.g. 
mean reduction in CTV65 D98%: 1.9 vs 0.4 Gy) and weight loss 
(e.g. mean increase in cord D2%: 2.2 vs 0.2 Gy). 
Conclusions: For the NPC cases studied, high quality plans 
were generated with all three techniques. IMPT 
demonstrated better PTV conformity and reduced dose to 
peripheral structures, the clinical significance of which is yet 
to be determined. On the other hand, IMPT was more 
susceptible to clinically observable anatomical changes.  
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The aim of radiation oncology is to eradicate tumor tissue 
while attempting to preserve function of adjacent organs and 
tissues. In the treatment of thoracic tumors the heart is often 
at risk. Finding an optimum between the probability of curing 
the patient and the risk of inducing complications requires 
e.g. predictive models for the risk of such complications. 
Current predictive models are generally based on one or 
more dose metrics, such as the (generalized) mean dose, 
volume receiving at least a defined minimum dose or the 
minimum dose to a defined fraction of the cardiac volume. 
The selection of these metrics, however, is generally based 
on assumed mechanisms and/or epidemiological parameter 
selection methods. As such, we hypothesized that a better 
understanding of mechanisms underlying cardiac damage may 
lead to improved selection of dose metrics for predictive 
models. 
We performed a number of studies on mechanisms of cardiac 
toxicity using the irradiated rat as a model. In short, thoracic 
sub-volumes were irradiated using high-precision proton 
irradiation to yield varying irradiated cardiac and lung 
volumes. We analyses cardiac and pulmonary histological and 
function changes and found that heart irradiation already 
resulted in cardiac damage at 8 weeks post-irradiation [1]. 
Moreover, we found that this damage was aggravated if also 
the lung was irradiated [1,2]. Finally, we found that 
Captopril could both ameliorate the cardiac damage and its 
impact on lung damage and function. Therefore we 
concluded that the radiation response of heart and lung are 
closely related and cannot be regarded independently. As 
such, adding dosimetric and/or clinical parameters related to 
the lung in the development of predictive models for 
radiotherapy-induced cardiac damage may improve the 
accuracy of such model.  
   
SP-0121   
Experimental models of radiation-induced heart disease 
M. Boerma1 
1University of Arkansas for Medical Sciences, Pharmaceutical 
Sciences, Little Rock, USA  
 
This presentation gives an overview of research performed in 
rat models of localized heart irradiation to address 
mechanisms by which ionizing radiation injures the heart. Rat 
models with mutations in the c-kit receptor gene have been 
used to investigate the role of mast cells in radiation-induced 
heart disease. The role of transforming growth factor-beta 
has been assessed by its pharmacological induction and the 
inhibition of its receptors. Moreover, rat models have been 
used to investigate whether the effects of radiation in the 
heart are different when radiation is combined with tyrosine 
kinase inhibitors, which have recently been associated with 
their own adverse cardiac effects.  
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A number of epidemiological studies have recently provided 
insight into the magnitude of the risk of heart disease 
occurring as a result of radiotherapy and into the factors that 
affect the risk.  In this talk, some of these results will be 
described. 
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Purpose/Objective: Adjuvant radiotherapy (RT) for left-sided 
breast cancer increases long term cardiac morbidity and 
mortality. No safe radiation threshold for heart is known. 
Troponin T is a sensitive marker of acute myocardial damage. 
Our aim was to evaluate the effects of left-sided breast 
cancer RT on high sensitivity cardiac troponin T (hscTnT) 
levels and possible associations with cardiac radiation doses 
and echocardiographic parameters. 
Materials and Methods: A total of 58 patients with an early 
stage left-sided breast cancer or ductal carcinoma in situ 
